HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guanwei Fan Selected Research

Xuebijing

4/2022The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
1/2018Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guanwei Fan Research Topics

Disease

26Inflammation (Inflammations)
03/2024 - 01/2015
17Myocardial Infarction
11/2023 - 06/2011
16Atherosclerosis
03/2024 - 11/2013
16Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 03/2011
14Heart Failure
11/2023 - 01/2016
11Reperfusion Injury
01/2023 - 01/2015
10Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 01/2015
8Fibrosis (Cirrhosis)
02/2023 - 12/2016
5Hypoxia (Hypoxemia)
10/2022 - 01/2018
5Neoplasms (Cancer)
01/2019 - 11/2017
4Heart Diseases (Heart Disease)
10/2023 - 12/2016
4Ischemia
12/2021 - 06/2011
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2021 - 01/2015
4Infarction (Infarctions)
10/2020 - 01/2018
4Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2017
3Non-alcoholic Fatty Liver Disease
11/2023 - 05/2020
3Cardiomegaly (Heart Hypertrophy)
02/2023 - 01/2016
3Sepsis (Septicemia)
10/2022 - 01/2018
3Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2019 - 09/2018
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 09/2018
3Brain Ischemia (Cerebral Ischemia)
01/2019 - 12/2016
3Vascular Remodeling
11/2018 - 01/2017
2Chronic Disease (Chronic Diseases)
11/2023 - 05/2019
2Cardiomyopathies (Cardiomyopathy)
01/2023 - 10/2022
2Insulin Resistance
03/2022 - 01/2022
2Hypertension (High Blood Pressure)
01/2022 - 01/2018
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 01/2021
2Ventricular Remodeling
12/2019 - 12/2016
2Cholestasis
05/2019 - 01/2019
2Ischemic Stroke
01/2019 - 01/2018
2Angina Pectoris
06/2018 - 11/2013
2Stroke (Strokes)
01/2016 - 11/2013
1Rheumatoid Arthritis
05/2024
1Arthritis (Polyarthritis)
05/2024
1Ulcerative Colitis
11/2023
1Metabolic Diseases (Metabolic Disease)
11/2023

Drug/Important Bio-Agent (IBA)

10danhongIBA
08/2019 - 11/2013
8LipidsIBA
03/2024 - 08/2015
7tanshinoneIBA
11/2023 - 06/2011
7HydrogelsIBA
12/2021 - 01/2018
5Therapeutic UsesIBA
03/2024 - 08/2012
5Proteins (Proteins, Gene)FDA Link
02/2023 - 01/2016
5RNA (Ribonucleic Acid)IBA
10/2022 - 01/2018
5Apolipoproteins E (ApoE)IBA
01/2022 - 01/2020
4Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2015
4AndrogensIBA
10/2019 - 01/2015
3yuanhu zhitongIBA
05/2024 - 02/2021
3oxidized low density lipoproteinIBA
03/2024 - 01/2018
3CytokinesIBA
03/2024 - 11/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 10/2020
3CholesterolIBA
01/2023 - 01/2016
3ginsenoside Rg3IBA
03/2022 - 11/2017
3Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2017
3Bile Acids and Salts (Bile Acids)IBA
02/2021 - 01/2019
3CollagenIBA
01/2021 - 10/2018
33,4-dihydroxyphenyllactic acidIBA
08/2019 - 01/2015
3radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA
06/2019 - 03/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 12/2016
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2019 - 01/2015
2IronIBA
03/2024 - 01/2023
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2023 - 10/2022
2TriterpenesIBA
01/2023 - 04/2017
2Messenger RNA (mRNA)IBA
04/2022 - 12/2016
2XuebijingIBA
04/2022 - 01/2018
2AntioxidantsIBA
01/2022 - 01/2019
2Nonprescription Drugs (Patent Medicines)IBA
11/2021 - 01/2018
2puerarinIBA
10/2021 - 12/2019
2Plant Preparations (Preparation, Plant)IBA
10/2021 - 02/2021
2Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2019
2Ion Channels (Ion Channel)IBA
01/2021 - 01/2020
2LigandsIBA
01/2021 - 01/2018
2GinsenosidesIBA
01/2021 - 10/2020
2Peptides (Polypeptides)IBA
05/2020 - 01/2020
2Fenofibrate (CiL)FDA LinkGeneric
05/2020 - 01/2019
2LipopolysaccharidesIBA
01/2020 - 01/2018
2IsoflavonesIBA
01/2020 - 01/2019
2wenxin keliIBA
01/2020 - 01/2017
2formononetinIBA
01/2020 - 01/2019
2Estrogen ReceptorsIBA
10/2019 - 01/2018
2Estrogens (Estrogen)FDA Link
10/2019 - 05/2019
2bakuchiolIBA
10/2019 - 09/2018
2salvianolic acidIBA
08/2019 - 06/2011
2MicroRNAs (MicroRNA)IBA
01/2019 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2018
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2019 - 01/2015
2shuxueningIBA
01/2019 - 01/2018
2Ginkgo biloba extract (Rokan)IBA
01/2019 - 01/2018
2ZSTK474IBA
01/2019 - 04/2016
2EnzymesIBA
06/2018 - 01/2015
2Shen-FuIBA
01/2017 - 01/2013
1Collagen Type II (Type II Collagen)IBA
05/2024
1PhytochemicalsIBA
11/2023

Therapy/Procedure

22Therapeutics
03/2024 - 01/2016
11Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 08/2012
3Injections
12/2021 - 01/2018
3Oral Administration
01/2021 - 11/2018
2Hematopoietic Stem Cell Transplantation
01/2020 - 01/2018
2Ligation
01/2019 - 06/2018
1Complementary Therapies (Alternative Medicine)
05/2024